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HUMAN AMNIOTIC MEMBRANE IMPROVES HEALING IN A CHRONIC,
MASSIVE ROTATOR CUFF REPAIR MODEL.
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Rotator cuff tendon heals by fibrovascular scar that is weaker than native tissue
leading to repairs that are prone to failure. To investigate the utility of an amnioticmembrane-derived human allograft in improving tendon-bone healing and skeletal
muscle architecture, a rotator cuff repair model in Sprague-Dawley rats was established,
tendon biomechanical testing, single muscle fiber biomechanical testing, microcomputed
tomography analysis, tendon and muscle histological analysis, and gene expression
analysis were performed. Our findings demonstrated single muscle-fibers with larger
cross-sectional area and greater maximum isometric and specific force in the augmented
experimental repair (ER) group. Additionally, microcomputed tomography revealed a
larger volume of newly formed bone and histomorphometric analysis demonstrated
significantly greater fibrocartilage area and collagen organization at the healing tendonbone insertion site in the ER group compared to the control repair (CR) group. Muscle
gene expression analysis revealed increased expression of COL1A1 and MMP-2 and

decreased expression of FITM-2 in the ER group compared to CR. These findings
revealed that augmentation with human amniotic membrane was associated with positive
effects on the entire muscle-tendon-bone unit. Based on these findings, we believe that
further investigation is warranted to optimize local and spatial delivery of amniotic
tissue-based products.
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Introduction
The rotator cuff is made up of four muscles (subscapularis, supraspinatus,
infraspinatus, teres minor) that are critical for maintaining glenohumeral joint stability
and mobility. Rotator cuff tears (RCTs) are a very common cause of disability and
discomfort in patients worldwide, with studies demonstrating a prevalence of up to 40%
in middle-aged populations.5 RCTs have also been shown to be responsible for 67% of
cases of shoulder pain and dysfunction in patients aged 40-65 years old.34 Massive rotator
cuff tears are defined as tears with a diameter ≥ 5 millimeters or detachment of two or
more tendons, with studies showing that massive tears make up to 10-40% of all RCTs.7
In addition to the significant disability caused by RCTs, they also represent an economic
impact upwards of three billion dollars per year in the United States alone.
Management of RCTs begins with conservative measures focused on decreasing
pain and improving function. Anti-inflammatory medications and physical therapy are
usually employed as first-line measures; however, surgical repair remains the goldstandard for definitive management of RCTs. Though major advances have been made in
surgical techniques, re-tear rates remain high, with some studies revealing rates of up to
94% for massive tears.11,30 Rotator cuff repair (RCR) failure can be defined as either
clinical or mechanical failure.28 Clinical failure occurs when patients continue to report
pain or functional impairment following repair, while mechanical failure occurs
secondary to a loss of fixation, failure to hear, or a repeat tear of the repaired tendon.28
The high incidence of re-tear is likely due to incomplete healing of the tendon-bone
insertion site secondary to the formation of a fibrovascular scar rather than recreation of
the native enthesis.26 Additionally, poor tissue quality as well as advanced fatty
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infiltration, both common attributes of chronic RCTs, are largely to blame for these high
failure rates.11 Incomplete structural healing of the repair construct leads to deficits in
rotator cuff strength and function,9,13,19 reducing the quality of life of afflicted individuals
and limiting their ability to complete activities of daily living.26
It has become clear that current surgical techniques, which have traditionally
relied on maximizing footprint restoration and construct stability, fail to provide a
biological environment necessary to recapitulate the processes that occur during
embryonic development to promote “scarless” healing of the enthesis. Rather, an adult
biologic milieu predominates, leading to inflammation and scar tissue formation,
inadequate tendon-bone healing, decreased postoperative muscle strength, and poor
shoulder mobility. In fact, Mirzayan et al. argue that the term “re-tear” inadequately
describes the complexity of post-repair failure as this implies that adequate healing of the
tendon to the tuberosity occurred when in reality, the tendon may have never actually
healed.28 Thus, there is a critical need to develop and utilize innovative treatments which
augment rotator cuff repair by recreating the fetal environment to reduce inflammation
and tissue degeneration and promote “scarless” healing of the enthesis, with the ultimate
goal of improving surgical outcomes.
Efforts to reduce the rates of failure following RCR have primarily focused on
improving fixation constructs. The introduction of double-row and transosseousequivalent repairs have resulted in increased mechanical strength, but these
improvements fail to address the critical biological component of tendon healing.17 To
create a more favorable local environment for healing, the use of biologics as adjunctive
treatments following RCR was introduced. To date, multiple biologic therapies have been
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studied including platelet-rich plasma (PRP), patches and scaffolds, mesenchymal stem
cells (MSCs), and cytokines.29 Several studies have outlined the potential benefits of
these therapies however, here we focused on the role of fetal tissue, specifically amniotic
membrane, to determine its ability to aid in proper rotator cuff tendon healing.
Utilization of fetal growth factors for biological augmentation holds great promise
for improving rotator cuff healing. Fetal tissues have been shown to have antiinflammatory properties and to promote scarless healing, leading to its use for several
clinical applications in ophthalmology, skin ulcers, burns, and surgical reconstructive
procedures.1 Within orthopaedics, fetal tissue has been used as a tendon wrap to reduce
inflammation and the formation of adhesions.1 In addition, previous work has shown that
delivery of transforming growth factor β3 (TGF-β3), which has been shown to promote
“scarless” healing in the fetal environment, at the repair site in a rat model of acute rotator
cuff injury and repair led to greater ultimate stress when compared to surgical repair
alone.21 Modulating the ratio of TGF-β1, which is highly expressed in adult healing, to
TGF-β3 may be important with greater TGF-β3 expression promoting a fetal wound
healing environment to promote tissue formation with a more favorable collagen I to
collagen III ratio.24 The recreation of a native tendon insertion site may be best achieved
with the delivery of undifferentiated stromal cells and growth factors in a coordinated
fashion. For example, previous work with amniotic tissue based products has shown that
local delivery of human amniotic fluid enhanced new cartilage formation from rabbit ear
perichondrial flaps subjected to a cartilage defect31 and improved fracture healing in a rat
tibia fracture model.24 Additionally, delivery of amniotic epithelial cells in a sheep
achilles tendon defect model was shown to promote mature collagen deposition and
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increased extracellular matrix remodeling.6 Also, the commercially available human
amniotic membrane graft used in this study (XWrap, Applied Biologics), which has a
relatively low cost, is easy to handle, and has acceptable suture-holding properties is
currently used to prevent perineural scarring in patients with cubital tunnel syndrome.15
Thus, the application of a minimally processed allograft containing amniotic stromal cells
and growth factors may be beneficial for tendon-bone healing following RCR.
The use of an amniotic membrane derived graft may hold an advantage over
existing approaches, such as stromal cell therapy alone20,33 or precursor gene delivery of
proteins implicated in tendon repair,21 because of the greater potential to recreate the fetal
environment at the repair site and promote native regeneration. The majority of studies
have focused on the use of a single compound, e.g. IGF-1, TGF-β1,23 or TGF-β3, but it is
unlikely that single factor therapy can reliably recreate the fetal environment compared to
a concentrate with amniotic derived stromal cells6 and growth factors.27 Additionally, a
key innovation of the amniotic-derived graft is the standardization of processing.
One challenge identified with other orthobiologics, such as the previously mentioned
PRP, is the product content variability within and between patients.3,12 The biologic
investigated in this study has been processed in a standardized manner providing for
more product consistency. Furthermore, the amniotic-derived graft proposed in this study
is FDA-approved for clinical use allowing for earlier translation to clinical trials to study
safety and efficacy.
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Statement of Purpose
Our objective was to investigate the ability of an amniotic membrane-derived
human allograft to improve rotator cuff tendon-bone healing and skeletal muscle
architecture in a chronic massive rotator cuff injury and repair model in Sprague-Dawley
rats. We hypothesized that application of human amniotic membrane to the tendon-bone
interface at the time of repair will result in (1) increased tendon-bone attachment strength
and (2) increased rotator cuff muscle fiber force secondary to improved bone formation,
increased fibrocartilage formation, improved collagen organization, less plasminogen
activator inhibitor-1 (PAI-1) expression, less lipid deposition, and induced muscle repair
gene expression compared to control repair.

Methods
Animal Model and Study Design
The Institutional Animal Care and Use Committee approved the protocols for
animal experimentation described in this study. Eighty-five male Sprague-Dawley rats
weighing approximately 350 grams were used. Twenty-five rats were allocated as
uninjured controls (U). The remaining 60 animals underwent unilateral full-thickness
rotator cuff injury of the supraspinatus (SSp) and infraspinatus (ISp) tendons and
concomitant injection with 3 units/kg per muscle of Onabotulinumtoxin A (Botox;
Allergan, Dublin, Ireland) into the SSp and ISp muscles to induce muscle atrophy. Thirty
days after injury, 10 animals were euthanized as injury-only (IO) controls and the
remaining 50 animals underwent rotator cuff repair utilizing a transosseous suture repair
technique. Twenty-five rats received a 5-mm diameter amniotic membrane patch at the
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site of tendon-bone repair (ER; experimental repair), while the remaining 25 animals
received no treatment to serve as control repairs (CR), which underwent repair but did
not have any biological augmentation. All repaired animals were allowed normal cage
activity and euthanized 30 days following rotator cuff repair.
Immediately following necropsy, animals were weighed and the SSp- and ISpmuscle-tendon-bone units were retrieved for analysis. Each tendon was transected from
the muscle 1 cm medial to its tendon-bone insertion site. For animals in the U, CR, and
ER groups, the humerus and attached tendons underwent either biomechanical testing
(n=15 per group) followed by micro-computed tomography analysis (n=5 per group), or
tendon histological analysis (n=5 per group). Each muscle was weighed then transected
into three one-cm sections. The lateral third underwent muscle histological analysis (n=8
per group), the middle third underwent single muscle fiber biomechanical testing (n=8
per group), and the medial third underwent gene expression analysis (n=8 per group).
Injury only (IO) animals underwent all of the aforementioned analysis methods with the
exception of tendon-bone biomechanical testing, tendon histological analysis, and muscle
weighing. To maintain consistency and single-surgeon validity, Dr. David Kovacevic
performed all procedures on living rats while post-mortem dissection and preparations
were performed by Maarouf Saad (MS), Robert Suriani Jr (RSJ), Jacob Berman (JB) and
Dr. David Kovacevic (DK).
Surgical Technique
Rotator Cuff Injury – Each animal was anesthetized with ketamine and xylazine
and placed in the supine position with 90° elbow flexion, forearm supination, and slight
shoulder external rotation while creating a 1.5 cm longitudinal anterior deltoid splitting
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incision. The deltoid was retracted to allow optimal visualization of the underlying SSp
and ISp tendons. A mosquito clamp was used to individually isolate each tendon,
followed by sharp transection of the tendon from the superior and middle facets of the
greater tuberosity bony footprint using an 11 blade. A silicone sleeve was attached using
4-0 nylon suture over the SSp and ISp tendons to reduce scarring and adhesion of the
tendons. An injection of 0.3 ml of 10 Units/ml Botox (3 Units per muscle, approximately
9 Units/kg/muscle) was injected into each muscle to chemically denervate the muscletendon units. The deltoid and skin were then closed using 4-0 Ethibond and 4-0 nylon
sutures. Subcutaneous buprenorphine and bupivacaine were administered for analgesia
during the 24-hour postoperative recovery period.
Rotator Cuff Repair – Thirty days following injury, animals in the CR and ER
groups underwent surgical repair. The same surgical incision and approach described
above were utilized to perform an anatomic rotator cuff repair utilizing a transosseous
cruciate tunnel technique. Careful dissection with small dissecting scissors exposed the
silicone tubes, which were removed to expose the distal muscle-tendon units. Using a 4-0
Ethibond suture, a modified Mason-Allen stitch was placed in both the SSp and ISp
tendons to create anterior and posterior suture limbs for each tendon. The bony footprint
of the greater tuberosity was then decorticated and three cruciate tunnels for both tendons
were created with a 22-gauge needle. Using a 4-0 Nylon suture, the 4-0 Ethibond suture
limbs were shuttled through the proximal tunnel aperture and out through the distal
tunnel exit. For animals allocated to the ER group only, a sterile 5 mm punch biopsy was
used to create a circular human amniotic membrane patch (XWrap Human Amniotic
Membrane; Applied Biologics, Phoenix, AZ). The biologic graft was then applied
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directly to the greater tuberosity footprint prior to fixation of the tendon to the bone. The
tendons were then tensioned to ensure maximal bone footprint coverage and then tied
over the proximal humeral cortical bone bridge. Deltoid closure, wound closure, and
postoperative recovery occurred as described in the above section and were identical
between groups. Rotator cuff injury and repair procedures were performed by DK to
maintain single-surgeon consistency within and between each group under investigation.

Tendon Biomechanical Testing
Cross sectional area of the SSp and ISp tendons were measured at the greater
tuberosity bony footprint using microCT. Humeri were potted in fast-curing epoxy to
facilitate gripping of the bone. Repair-site sutures were cut and carefully removed to
ensure no contribution of the suture during tension-to-failure tests. Specimens were kept
moist with phosphate buffered saline throughout testing. Tests were performed on a
single column, tabletop testing system (Instron 5542, Norwood, MA) with a 500 N load
cell and custom fixtures. The top grip was lined with sandpaper and coated with
cyanoacrylate to prevent slipping of the tendon. The bottom grip allowed for adjustment
of the angle of the humerus such that the tendon was pulled in line with the angle of
insertion. Tests were performed for tensile loading of the ISp and SSp first with stress
relaxation (100%/s ramp followed by 5% strain hold for 300 s). Specimens were then
extended to failure at a rate of 0.2%/s. Strain was measured globally as grip-to-grip
displacement relative to the initial gauge length for each tendon measured with digital
calipers (Starrett, Athol, MA). Stiffness and Young’s modulus were calculated by
measuring the slope of the linear region of force-length and stress-strain curves,
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respectively, for both ISp and SSp tendons. Failure mechanisms were assessed, and
maximum load, maximum stress, and toughness were calculated. Tendon biomechanical
testing was performed by Dr. Steven Tomassini and data interpretation was performed by
MS, RSJ, Dr. Steven Tomassini (ST), and DK.
Muscle Single Fiber Biomechanical Testing
Bundles of muscle fibers approximately 5 mm in length and 0.5 mm in diameter
were dissected from the middle third of each SSp muscle prior to preparation. The
bundles were initially placed in a cold skinning solution with 0.5% Brij 58 for 30 minutes
before being placed into a storage solution for overnight shipment from Yale University
to the University of Michigan at 4ºC. Upon arriving at the University of Michigan, the
SSp bundles were stored at -80ºC until use.
On the day of testing, bundles were thawed on ice and individual fibers were
pulled from bundles using fine mirror-finished forceps. Fibers were then quickly placed
in a custom-designed chamber containing relaxing solution and secured at one end to a
servomotor (Model 322C, Aurora Scientific, Aurora, ON) and the other end to a force
transducer (Model 403A, Aurora Scientific) using two ties of 10-0 monofilament nylon
suture at each end of the fiber. Using a laser diffraction measurement system, the length
of each fiber was adjusted to obtain a sarcomere length of 2.5 µm and fiber length (Lf)
was then measured. The average cross-sectional area (CSA) was calculated assuming an
elliptical fiber cross-section, with diameters obtained at five different equidistant
positions along the fiber from high-magnification images of the top and the side views.
Relaxed fibers were then prepared for force measurement by initially immersing
them in a low [Ca2+] pre-activating solution for 3 minutes. The purpose of submerging
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fibers in the pre-activating solution, which was weakly buffered for Ca2+, was to allow
for rapid activation of the fibers and subsequent force development once they were
placed in the activating solution. Maximum isometric force (Fo) was then elicited by
immersing the fiber in a high-[Ca2+] activating solution. Fo was determined by measuring
the difference between the force produced when the fiber was stretched to Lf and that
obtained at the point of maximal contraction. Following activation and fiber contraction,
specific force (sFo) was calculated by dividing Fo by the pre-measured CSA. Forty-eight
fast fibers were tested from each group (6 individual muscle fibers per specimen; n=8
specimens per group). Testing and analysis were performed in a blinded fashion. All
single muscle fiber experiments were completed by MS with assistance from Jeff Kepple
(JK) under the guidance of Dr. Chris Mendias (CM) and Dr. Dennis Claflin (DC).
Microcomputed Tomography Analysis
Five animals from each group were allocated to undergo microcomputed
tomography analysis. Following biomechanical testing, the humerus samples were fixed
in a 1:1 solution of ethanol and sterile water and microcomputed tomography analysis of
the most proximal 1 cm of the humerus was performed using a CT 35 scanner (Scanco
Medical, Wangen-Bruttisellen, Switzerland) at 10 mm isotropic resolution. Using the
obtained 3-dimensional renderings, the surface area of the SSp and ISp bone insertions on
the greater tuberosity were measured as well as the bone volume to total volume ratio,
trabecular spacing, trabecular thickness, and trabecular number. MicroCT preparation and
procedures were performed by RSJ. and DK while data analysis was performed by MS,
RSJ, and DK.
Tendon Histological Analysis
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Humerus samples with attached SSp and ISp tendons (U, ER, CR, n=5 per group)
were fixed in 10 % neutral buffered formalin, then decalcified using Deltaform
decalcifier (Delta Medical, Aurora, IL) on a shaker in the cold room for 7 days, changing
the decalcification solution every other day. Once decalcified tissue was processed via
routine paraffin methods. Coronal sections were cut at 5 m and stained with Hematoxylin
& Eosin, Safranin O, and Picrosirius Red. New fibrocartilage formation at the enthesis
was quantified by imaging Safranin O-stained sections at 10x magnification and
measuring total metachromasia area using ImageJ software (National Institutes of Health,
Bethesda, MD).
Picrosirius red-stained sections were imaged under polarized light microscopy at
10x magnification using an Olympus BX40 microscope (Olympus, Tokyo, Japan) with a
custom polarizing setup. The rotary polarizing filter was oriented perpendicular to the
polarizing analyzer to create a dark field under which collagen birefringence was visible.
The tendon enthesis of each sample was oriented within the field and rotated through
360°. The orientation of maximum birefringence at the enthesis was noted and imaged.
Using ImageJ software, the images were converted to 8-bit grayscale and calibrated to a
linear brightness curve on a scale of 0 (black) to 255 (white). Ten 50x50m representative
boxes were randomly selected from each image, the mean brightness of each square area
was measured, and the 10 measurements were averaged for each sample.
Immunohistochemistry was performed to localize Plasminogen Activator
Inhibitor 1 (PAI-1) expression in tendon sections. Prior to staining, slides were
deparaffinized and rehydrated through a graded ethanol series to distilled water. Antigen
retrieval was done in citrate buffer (0.3%) heated to 100°C for 20 minutes. Following
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antigen retrieval, slides were washed in PBS, then quenched in a mixture of 90 ml
methanol and 10 ml of 30% hydrogen peroxide to remove endogenous
peroxidase. Following quenching, slides were washed three times in tris buffered saline
containing .05% Triton X (TBST). Blocking was done using Biocare Rodent M (Biocare
Medical, Pacheco, CA) for 20 minutes. After washing 3 times in TBST, primary
antibody was applied to slides (PAI-1- rabbit polyclonal, cat # Ab217288, Abcam) and
incubated overnight in a moisture chamber at 4°C. The following day, slides were rinsed
3 times in TBST and secondary antibody, Biocare rabbit on rodent HRP polymer
(Biocare Medical, Pacheco, CA) for 30 minutes at room temperature. Slides were again
rinsed 3 times with TBST and chromogenic staining was done using the Betazoid DAB
kit (Biocare Medical, Pacheco, CA). DAB staining was developed on ice for 1-2
minutes, then slides were washed with distilled water. Counterstaining was done using
hematoxylin and slides were dehydrated through graded ethanol baths, cleared in xylenes
and cover-slipped. Images were graded on a semi quantitative scale from 0 (undetectable)
to 3 (high) in a blinded fashion. Tendon histological analysis was performed by MS, RSJ,
and DK.
Skeletal Muscle Histological Analysis
Muscle samples were mounted on 1” cork discs using a pyramid of 10% gum
tragacanth, snap-frozen in liquid nitrogen-cooled isopentane maintained at -160°C and
immediately transferred to a -24°C cryostat. Due to the need for rapid freezing to
maintain muscle fiber microarchitecture, the samples were cut without additional
mounting. Sections were cut at 10 mm, which was the minimum thickness necessary to
maintain section integrity. Frozen sections were carefully transferred to charged slides
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using a fine paintbrush, and then different sections from each sample were stained for
Hematoxylin & Eosin or an immunological stain multiplex consisting of DAPI (Sigma
Aldrich, St. Louis, MO), WGA Lectin (Thermo Fisher, Hampton, NH), and BODIPY
(Thermo Fisher). For immunostained slides, sections were fixed with 4%
paraformaldehyde and permeabilized with 0.2% TBST, then stained in succession in a
dark hydration chamber with BODIPY (3 hours), WGA-Lectin Texas Red (15 minutes),
and DAPI (10 minutes). Sections were washed with phosphate-buffered saline three times
following each step.
Fluorescent slides were visualized and imaged with a Leica SP5 Fluorescent
Microscope (Leica Microsystems, Wetzlar, Germany). Muscle cross-sectional area
(CSA) of each sample was measured using ImageJ software. Quantification of fat
deposition within muscle sections was performed by first taking five representative
images [four quadrants (upper, lower, left, right) and center] of each section at 10x
magnification. Images of the BODIPY-only channel were converted to 8-bit grayscale
using ImageJ and a brightness threshold was set to measure the area of staining against
the dark field background. The BODIPY staining area measurements obtained from the
five images of each sample were averaged. Muscle histological analysis was performed
by MS, RSJ, and DK.
Human Amniotic Membrane-Derived Graft Histological Analysis
A sample of the human amniotic-membrane allograph was processed via routine
paraffin methods and longitudinal sections were cut and stained with Hematoxylin &
Eosin, DAPI, Masson’s trichrome, and Toluidine blue. Immunostained slides were
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prepared and analyzed as previously described. Graft histological analysis was performed
by MS, RSJ, and DK.
Gene Expression Analysis
Total RNA for gene expression analysis was isolated from the supraspinatus
muscle. Frozen tissue samples (~20mg) were disrupted (BR12, Omni, Kennesaw, GA) in
1ml of Tri Reagent and prepared according to the manufacturer (Molecular Research
Center, Inc, Cincinnati, OH). RNA concentration and quality were assessed using a
NanoDrop 2000 (Thermo Scientific, Waltham, MA). Quality of RNA was assessed using
the 260/280 and 260/230 ratios. A DNA removal kit was used to treat 5µg of RNA (DNAfree, Invitrogen, Waltham, MA). Afterwards, 1µg of RNA was reverse transcribed into
cDNA (iScript, BioRad, Hercules, CA). Relative mRNA quantification was completed in
duplicates on a CFX Connect real time detection system (BioRad) using self-designed or
pre-validated (Prime PCR, BioRad) SYBR Green assays. Values were normalized to betaactin (ACTB) and fold change was calculated from the uninjured control [SHP1] samples
using the 2-∆∆Ct method.15 Validation of the housekeeping gene (ACTB) was performed to
ensure that its expression was not affected by experimental treatments. Muscle gene
expression PCRs were performed by Dr. Chad Carroll (CC) and results were analyzed by
MS, RSJ, CC, and DK.
Statistical Analysis
Statistical analysis was performed for all analysis methods using a nonparametric
Wilcoxon Rank-Sum test with appropriate post hoc testing. Significance was set at p <
0.05. Statistical analysis was performed by MS and RSJ.
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Results
Gross Observations
At time of necropsy, tendons were atrophied, pale yellow and gelatinous in
appearance. There was poorly organized, white fibrous tissue surrounding the tendonbone insertion site in all surgical groups. These changes were more pronounced in
animals sacrificed at 8 weeks (CR, ER) compared to those sacrificed at 4 weeks
(IO). The amniotic membrane placed at the repair site of animals in the ER group was
not visible in any sample. The repaired tendon was in continuity with the bone in all
samples, signifying successful and acceptable RCR in all animals undergoing further
testing.
Tendon Biomechanical Testing
Tendon biomechanical testing revealed that augmentation with human amniotic
membrane did not lead to any significant difference in the physical characteristics or
performance of samples from the CR or ER groups. Specifically, ultimate load-to-failure
(LTF) did not differ significantly between any of the experimental groups (Uninjured
(U): 22.97 ± 2.57 N, Control Repair (CR): 24.71 ± 2.73 N, Experimental Repair (ER):
24.35 ± 1.79). Stiffness also did not differ significantly between any of the experimental
groups (U:14.59 ± 3.36 N/mm; CR:12.56 ± 1.54 N/mm; ER: 12.89 ± 1.24 N/mm).
Displacement to failure (DTF) was greater in the CR and ER groups compared to
the U group (U: 1.42 ± 1.00 mm, CR: 3.32 ± 1.32 mm p<0.0001, ER: 3.53 ± 1.67 mm
p<0.0001) but did not differ significantly between the CR and ER groups. Work to failure
(WTF) of the CR and ER groups were also significantly greater than that of the U group
without a significant difference between the CR and ER groups (U: 33.80 ± 26.10 mJ,

16

CR: 83.68 ± 37.41 mJ p<0.0001, ER: 87.00 ± 42.99 mJ p<0.0001). Strain in the CR and
ER groups was significantly greater than the U group (U:18.87 ± 14.20%; CR: 37.52 ±
17.70 p<0.0001; ER: 32.45 ± 21.88% p=0.0041), again without a significant difference
between the CR and ER groups.
Modulus was significantly decreased in the CR and ER groups compared to the U
group (U: 4.88 ± 3.61 MPa; CR: 2.71 ± 1.74 MPa p=0.02; ER: 2.54 ± 1.16 MPa p=0.02).
Tendon biomechanical testing was not performed on the injury-only (IO) group.

DTF
(mm)

Stiffness
(N/mm)

WTF
(mJ)

Max
Stress
(MPa)

Strain
(%)

Modulus
(MPa)

U
22.97 ±
(n=30) 2.57

1.42 ±
1.00

14.59 ±
3.36

33.80 ±
26.10

0.45 ±
0.38

18.87 ±
14.20

4.88 ± 3.61

CR
24.71 ±
(n=30) 2.73

3.32 ±
1.32*

12.56 ±
1.54

83.68 ±
37.41*

0.56 ±
0.41

37.52 ±
17.70*

2.71 ± 1.74*

ER
24.35 ±
(n=30) 1.79

3.53 ±
1.67*

12.89 ±
1.24

87.00 ±
42.99*

0.50 ±
0.30

32.45 ±
21.88*

2.54 ± 1.16*

LTF (N)

Table 1. Tendon biomechanical testing revealed that augmentation did not lead to any
significant difference in the physical characteristics or performance of samples from the
CR and ER groups. Results are reported as mean ± standard error of the mean. LTF: Load
to Failure, DTF: Displacement to Failure, WTF: Work to Failure. *Statistically
significant difference (P < 0.05) compared to the Uninjured group.
Single Muscle Fiber Biomechanical Testing
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Mean fast fiber cross-sectional area (CSA) was significantly reduced in all
surgical groups compared to U [U=5503 ± 843 μm2, IO=3147 ± 1369 μm2 (p<0.0001),
CR=1728 ± 1053 μm2 (p<0.0001), ER=3713 ± 2676 μm2 (p=0.0002)]. CSA of the ER
group was significantly greater than the CR group (p<0.0001), representing a 32.5%
reduction from mean U group CSA and a 68.5% reduction in the CR group CSA
compared to U group CSA. In addition, the mean CSA of the ER group was 18.0%
greater than the IO group while that of the CR group was reduced by 44.7% compared to
IO.
Mean specific force produced by fast fibers was greatest in the U group (140±10
kPa), with that of the IO (121±22 kPa) and CR groups (120±33 kPa) being significantly
lower (p=0.0147, p=0.0098) than that of the U group. The mean specific force produced
by fibers in the ER group (138±13 kPa) was significantly greater than the CR (p=0.0247)
and IO (p=0.0358) groups but did not differ significantly from the U group.
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Figure 1. Single muscle fiber biomechanics. A, cross sectional area was greater in the ER
group compared to the CR group; The ER group also generated greater (B) maximum
isometric force and (C) specific force than the CR group.
Microcomputed Tomography (Micro-CT) Analysis
New bone formation, quantified by the ratio of bone volume to total volume, was
significantly lower for all surgical groups compared to the U group [U: 0.48 ± 0.053, IO:
0.31 ± 0.067 (p<0.001), CR: 0.32 ± 0.051 (p<0.001), ER: 0.39 ± 0.099 (p<0.001)], but
greater for the ER group compared to CR group (p=0.006). The ER group, but not the CR
group, had significantly more new bone formation than the IO group (p=0.045). While
trabecular thickness did not differ significantly between groups, trabecular number was
significantly decreased and trabecular spacing was significantly increased in all surgical
groups compared to the U group.
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Figure 2. A, three-dimensional reconstruction of microCT images of the proximal
humerus, including the lesser tuberosity bony footprint (A), bicipital groove (B), greater
tuberosity supraspinatus bony footprint (C) and greater tuberosity infraspinatus bony
footprint (D). B, new bone formation quantified as bone volume/total volume (BV/TV)
expressed as a percentage of maturing bone at the SSp and ISp footprint shows more new
bone formation in the ER group compared to all other groups.
Tendon Histological Analysis
Mean collagen birefringence of picrosirius red-stained tendon sections was
greatest in the ER group (82.7 ± 21.4), which was significantly greater than that of the
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CR group (55.7 ± 25.8, p=0.017) and not significantly different from the U group (78.3 ±
28.6). The mean area of metachromasia measured in safranin O-stained sections, which
quantified enthesis proteoglycan content, was greatest for the U group (415 ± 218
µm2/1000). While mean metachromasia measured for the CR group (72.8 ± 78.5
µm2/1000) was less than that of the ER group (200 ± 159), this difference did not achieve
significance. PAI-1 immunohistochemistry semi-quantitative grading showed no
significant differences between any groups.

Figure 3. A, sections for H&E (a-c), Safranin O (d-f), Picrosirius Red (g-i), and PAI-I (jl). B, (a) augmentation with amniotic membrane-derived graft did not improve the area
of new fibrocartilage formation at the enthesis in the ER group compared with the CR
group; (b) but did improve collagen fiber continuity and orientation at the enthesis in the
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ER group compared to the CR group and (c) semi-quantitative grading showed no
significant difference between any groups.
Muscle Histological Analysis
Mean muscle fiber CSA was not significantly different between any groups (U=
0.95 ± 0.05 mm2, IO= 0.75 ± 0.04 mm2, CR= 0.54 ± 0.12 mm2, ER=0.55 ± 0.18 mm2).
Mean area of lipid deposition, visualized by BODIPY staining, was decreased in the ER
group compared to the CR group albeit not significantly.

Figure 4. A, sections for H&E (a-d), WGA (e-h), and BODIPY (i-l). B, muscle fiber
cross-sectional area was decreased in the CR and ER groups compared to the U group but
there was no difference between the CR and ER groups. C, there was no statistically
significant difference in fat deposition between the groups.
Muscle Mass
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Combined mass of the supraspinatus and infraspinatus muscles standardized by
total body mass (SS+IS/TBM), was significantly greater in the U group compared to the
repaired groups [U=0.0010 ± 0.0002 g, CR=0.0005 ± 0.0002 (p<0.005), ER= 0.0003 ±
0.0003 (p<0.001)]. SS+IS/TBM did not differ significantly between ER and CR groups.
Muscle mass analysis was not completed for the IO group.

Uninjured (n=8)
Injury Only
Control Repair (n=7)
Experimental Repair (n=13)

SSp + ISp Mass (g)

Total Mass (g)

SSp+ISp/Total Mass

0.46 ± 0.048
Not Reported
0.26 ± 0.056b
0.23 ± 0.077c

462 ± 18
Not Reported
485 ± 44
509 ± 30

0.0010 ± 0.0002
Not Reported
0.0005 ± 0.0002a
0.0003 ± 0.0003c

Table 2. Combined supraspinatus and infraspinatus mass and mass as a ratio of body
weight were significantly decreased in the CR and ER groups compared to the U group
but did not differ between the CR and ER groups. Statistically significant difference
compared with the uninjured group: a:P < 0.005, b:P < 0.0005, c:P < 0.0001. SSp:
Supraspinatus, ISp: Infraspinatus, TBM: Total Body Mass. U, uninjured; IO, injury only;
CR, control repair; ER, experimental repair
Gene Expression Analysis
Results of quantitative real-time PCR, reported as fold-changes relative to the U
group, are reported in figure 5. Expression of COL1A1 and MMP-2 was greater in the ER
group compared to CR [CR: 1.66  1.41, 2.09  1.55 p = 0.04; ER: 5.43  3.07 p= 0.02,
6.14  4.00 p= 0.02]. Additionally, relative expression of FITM-2 was lower in the ER
group compared to CR [CR: 3.02  1.06; ER: 1.72  1.01 p = 0.02].
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Figure 5. Relative expression of genes implicated in collagen formation (A) and
extracellular matrix regulation (D) demonstrated increased expression in the ER group
compared to CR of COL1A1 and MMP-2, respectively. Expression of genes implicated in
adipogenesis (B) revealed decreased expression of FITM-2 in the ER group compared to
CR. There was no difference between the CR and ER groups in genes that function as
growth factors/cytokines (E), or apoptosis regulators (C).
Human Amniotic Membrane-Derived Graft Histological Analysis
The cellular composition of the graft was characterized by Hematoxylin & Eosin,
Masson’s trichrome, DAPI, and Toluidine blue. Interpretation of the stains demonstrated
the presence of cytoplasm, nuclei, and collagen and the absence of proteoglycans.
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Figure 6. A, H&E stain reveals the presence of nuclei (blue/purple) and cytoplasm (red);
B, Masson’s trichrome shows the presence of collagen (blue) and cytoplasm (pink); C,
DAPI shows the presence of nuclei (blue); D, Toluidine blue reveals the absence of
proteoglycans in the graft.
Conclusions
Degenerative rotator cuff tears are one of the most common pathologies seen in
the orthopaedic clinic and operating room. Great strides have been made in surgical
management of such tears over the past two decades, thanks in large part to the
advancement of minimally invasive arthroscopic surgery and the push to continue
producing innovative and highly effective orthopaedic implants. It is clear however, that
a strictly mechanical approach fails to adequately address the relatively high rates of
tendon re-tear or failure of primary tendon healing following repair. The goal of this
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study was to establish a reliable rat model for chronic, massive rotator cuff tears which
was to be used to study the possible advantages of augmenting RCR with human
amniotic membrane. Specifically, we tested the hypotheses that application of human
amniotic membrane to the tendon-bone interface at the time of repair can (1) strengthen
the enthesis and (2) produce greater rotator cuff muscle fiber force by promoting bone
formation, increase fibrocartilage formation, improve collagen organization, demonstrate
lower levels of plasminogen activator inhibitor-1 (PAI-1), exhibit less lipid deposition,
and induce muscle repair gene expression compared to control repair.
To determine the degree of new bone formation at the healing enthesis we
performed microcomputed tomography (Micro-CT) analysis. Our results demonstrated a
higher degree of newly formed bone in the repairs augmented with human amniotic
membrane compared to control repairs. To fully appreciate these findings, it is important
to understand the structural characteristics of the tendon-bone interface and the
modulators of this process. A fibrocartilaginous transition area exists between tendon and
bone, which can be divided into four distinct areas including tendon, fibrocartilage,
mineralized fibrocartilage, and bone.35 Previous studies have demonstrated that TGF-β1
enhances the formation of fibrous tissue at the site of tendon healing through the
downregulation of matrix metalloproteinase 9 and 13 (MMP-9, MMP-13).2
In addition to identifying macroscopic changes, we sought to study the effects of
human amniotic membrane on the microscopic architecture of the muscle-tendon units.
Several histochemical techniques exist that allow for enhanced visualization of collagen
including Masson trichrome, van Gieson, Herovici, and picrosirius red. Though the
interpretation of all these stains is straightforward, we chose to utilize a picrosirius red
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stain as the Masson, von Gieson, and Herovici stains require reactions with proteins of
which the mechanism of action remains unclear, leading to decreased selectivity for
collagen fibrils. The picrosirius red stain relies on the fact that collagen is highly
anisotropic and thereby birefringent. Birefringence is the difference in the refractive
indices of the two rays, oriented ninety degrees apart, that are produced when light
interacts with an anisotropic molecule like collagen. Picrosirius red is also a highly
birefringent molecule which binds to collagen and orients parallel to the fibrils thereby
allowing the collagen-picrosirius red complexes to be visualized easily under polarized
light. This process allows for the determination of collagen organization at the enthesis,
with more organized collagen being associated with a more robust and reliable construct.
Analysis of the tendons obtained from rats having undergone augmented repairs with
amniotic membrane demonstrated greater organization than those in the control repair
group. These findings indicate that augmentation with human amniotic membrane may
also play a role in improving repair integrity on a microscopic, organizational level.
Skeletal muscle atrophy and fatty degeneration of the rotator cuff is a common
phenomenon following RCT. We found that the combined mass of the SSp and ISp
muscles in the CR and ER groups was significantly lower than that of the U group, but
there was no difference between the CR and ER groups. Notably, our model was
designed to model chronic tears, and this was achieved in part by the denervation of the
rotator cuff with botulinum toxin. Furthermore, it is believed that myotendinous
retraction that occurs following RCT could lead to traction injury to the suprascapular
nerve, thereby contributing to the denervation of the cuff and subsequent muscle
atrophy.18
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To further characterize the skeletal muscle changes in the study groups, we
performed muscle histological analysis. Hematoxylin & Eosin (H&E) staining allowed
for the measurement of individual muscle fibers and showed that the average crosssectional area was decreased in the CR and ER groups compared to the U group, but
again there was no difference between the CR and ER groups. Though we were unable to
identify a statistically significant difference, we observed a higher rate of fat deposition in
the CR and ER groups compared to the U group. These findings demonstrate that our
model for chronic, massive rotator cuff tears led to increased muscle atrophy, a
characteristic feature of RCT pathophysiology. Unfortunately, our model failed to
produce significantly higher rates of fatty degeneration, which may be due to the short
time period between injury, repair, and sacrifice. This could also be a species-specific
issue as the rat rotator cuff is a good, but clearly not perfect representation of the human
rotator cuff both mechanically and biologically.
The completion of gene expression analysis also served to uncover the possible
mechanisms by which human amniotic membrane serves a beneficial role following
RCR. The relative degree of messenger RNA (mRNA) production of the genes of interest
was used as an indicator of gene expression and ultimately protein production leading to
downstream effects. The reverse transcription of mRNA, the molecules destined for
translation and protein production, to complimentary DNA (cDNA) allows for the
completion of quantitative real-time polymerase chain reaction (qRT-PCR) to determine
relative gene expression. In completing these experiments, we were able to identify
upregulation of the genes COL1A1 and MMP-2 as well as downregulation of FITM-2 in
the ER group compared to the CR group.
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The COL1A1 gene encodes the α1 chains of type-1 collagen.22 Type-1 collagen
serves as the main structural component of tendons, though it is not a tendon-specific
structure that is also present in large quantities in the bone, skin, and cornea.16 As
previously mentioned, tendons are composed of highly coordinated, parallel collagen
fibrils however, the process by which these fibrils organize remains unknown. Taken
together with our histological studies that demonstrated increased collagen organization
at the enthesis in the ER group, increased expression of COL1A1 further supports the
finding that human amniotic membrane has a positive effect on tendon healing following
repair. Additionally, MMPs are proteases that play a critical role in healing and
remodeling. Previous studies have shown that MMPs, specifically MMP-2 and MMP-9,
demonstrate low levels of expression under physiological conditions but are upregulated
following tendon injury.8 Specifically, MMP-2 has been shown to play a critical role in
both the degradation and remodeling of collagen.10 Our results demonstrated a
statistically significant increase in MMP-2 expression in the ER group compared to all
other study groups, uncovering a possible mechanism for the potential role of amniotic
membrane in tendon healing following injury and repair.
In addition to upregulated COL1A1 and MMP-2 expression, the ER group
demonstrated decreased expression of FITM-2 compared to the CR group. This gene
codes for a transmembrane protein that may play a role in fatty degeneration of rotator
cuff muscle after injury14. The structural composition of the rotator cuff changes
following injury, particularly following full thickness tears. When a tear occurs, the
muscle fibers are reoriented in such a way that gaps are formed which leads to fatty
infiltration as these gaps are filled with fat and fibrous tissue.4 Studies have shown that
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muscle fat content (MFC) following RCT is associated with patient age and gender, but
little is known regarding the underlying mechanisms guiding this phenomenon.4 The
downregulation of FITM-2 provides a possible explanation for one of the steps involved
in this process, and decreased expression following augmentation with amniotic
membrane further demonstrates the positive effects of this graft on healing following
RCR.
Tendon biomechanical testing failed to demonstrate a difference in the structural
properties of the tendons following augmentation with human amniotic membrane. The
repaired tissues under study consisted of healing scar tissue as well as the native tendon,
making up a very complex tissue composite. As a result of this composition, construct
failure during testing did not always occur at one particular moment in time as the scar
tissue may have failed first, followed by the native tendon tissue. Despite the previously
mentioned increase in bone formation and improved collagen organization identified in
the ER group, differences in the composition of the tendon samples within and between
each study group may have contributed to the finding of similar biomechanical
properties, particularly load to failure, between the CR and ER groups.
Though there were no biomechanical differences identified through tendon
biomechanical testing, single muscle fiber biomechanical testing served to further
characterize the muscle atrophy previously described as well as demonstrate
biomechanical differences between our study groups. H&E staining showed that average
muscle fiber cross-sectional area was decreased in the CR and ER groups compared to
the U group. In competing single-muscle fiber testing, we were able to measure
individual fibers by isolating them from each muscle bundle. Highly magnified images
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were taken of each fiber at five distinct points along its length, which were then were
used to determine the CSA of each fiber. This method of determining CSA was more
precise than the previously described histological analysis, and we were able to determine
that there was a difference between the CR and ER groups, with the fibers in the
augmented repair ER group demonstrating a higher CSA than those in the CR group. We
were also able to identify increased specific force in the fibers isolated from the ER group
compared to the CR group. The measurement of specific force takes into account the
CSA of the muscle fibers, which was critically important as the fibers in the ER group
were shown to have a higher CSA than those in the CR group. The increased specific
force produced by the fibers in the ER group was likely made possible by the more
favorable biological environment afforded by the amniotic membrane. Decreased
inflammation and fatty degeneration may have played a key role in the demonstrated
findings. Additionally, amniotic membrane has been shown to reduce fibrosis in the
extra-ocular muscles following strabismus surgery therefore, amniotic membrane may
play a role in decreasing the interstitial fibrosis of rotator cuff muscles following tendon
injury in RCTs.25 These findings have provided a strong foundation for further work
elucidating the underlying mechanisms associated with improved muscle fiber
characteristics.
We acknowledge that modeling of chronic injury and repair in a small animal
model can be challenging, especially when it comes to mimicking a clinical scenario in
which there are at least equal amounts of fat and muscle in the rotator cuff. Despite
unloading the tendon and chemically denervating both the supraspinatus and
infraspinatus tendons for four weeks, we were able to achieve Goutallier stage 2 “fatty
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atrophy” changes in this massive rotator cuff injury and repair model. We may have
considered delaying the repair for either six or eight weeks after the original injury, but it
is highly likely a suitable repair would have been even more difficult to
achieve. Performing a repair at 4 weeks following injury, considerable dissection was
required to mobilize both rotator cuff muscle tendon-units to ensure adequate tendon
excursion to maximize footprint restoration. There is no doubt that the manipulation of
the muscle during the repair led to additional muscle injury. A second limitation of this
study is that it was powered for maximum load to failure of the healing enthesis. This
outcome measure, which is a macroscale tool for evaluation of the composite tissue, may
not provide an accurate estimate of the attachment strength of a complex tissue that
includes fibrovascular scar. Rather, we believe that a microscale tool such as atomic force
microscopy (AFM) would be ideally suited to evaluate tendon bulk samples at the microand nanoscale.32 AFM can be used to measure indentation modulus of small animal
tissues by using micro- and nanoscale probes to indent the tissue, providing a measure of
the elastic modulus that cells are experiencing at the cell length-scale. A third limitation
is that we only augmented the tendon-bone repair site despite unloading the tendon and
chemically denervating the muscle. It is possible that augmentation of the muscle with
amniotic fluid would lead to less muscle fibrosis. Future work will be focused on
evaluating the role of amniotic fluid injection of the injured rotator cuff muscle.
There are several strengths to this work. All of the surgical injuries and repairs
were executed and completed by a fellowship-trained surgeon who has extensive
experience with small and large animal models of tendon-bone healing. This quality
control eliminated any variability that may be seen with surgical repair performed among
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several individuals. Also, we performed a comprehensive evaluation of the entire muscletendon-bone unit in this pre-clinical model of chronic injury and rotator cuff repair.
Third, we characterized the enthesis material properties as well as the structural
properties of the tendon-bone construct.
In summary, based on our comprehensive evaluation of the entire muscle-tendonbone unit, delivery of human amniotic membrane at the rotator cuff tendon-bone
footprint can improve healing after repair in a chronic, massive rotator cuff injury model.
This is evidenced by greater bone formation, a more organized tendon enthesis, induced
muscle repair gene expression, and greater rotator cuff muscle fiber force.
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